SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
397.50    0.00 (0.00%)
Bid:
385.00
Ask:
410.00
Spread: 25.00 (6.494%)
Market Cap: £427.26m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
11th Jun 20267:00 amRNSQ3 Trading Update
3rd Jun 20262:48 pmRNSRe-issue of Treasury Shares
2nd Jun 20267:00 amRNSChange of Nominated Adviser
15th May 20267:45 amRNSDirector Declaration
1st May 20268:56 amRNSBlock Listing Six Monthly Return
20th Apr 20266:30 pmRNSRe-issue of Treasury Shares
20th Mar 20267:00 amRNSAgreement to Acquire Clarendon Agricare
9th Mar 20262:19 pmRNSRe-issue of Treasury Shares
9th Mar 20262:19 pmRNSRe-issue of Treasury Shares
5th Mar 20262:07 pmRNSRe-issue of Treasury Shares
3rd Mar 20265:20 pmRNSHolding(s) in Company
3rd Mar 20264:50 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:43 pmRNSDirector/PDMR Shareholding
3rd Mar 202611:13 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSInterim Results Statement
20th Feb 20262:35 pmRNSRe-issue of Treasury Shares
10th Feb 20267:00 amRNSCurrency Change
28th Jan 20264:08 pmRNSHolding(s) in Company
26th Jan 20265:14 pmRNSHolding(s) in Company
22nd Jan 20264:02 pmRNSRe-issue of Treasury Shares
20th Jan 20262:02 pmRNSRe-issue of Treasury Shares
16th Jan 20264:45 pmRNSRe-issue of Treasury Shares
12th Jan 20261:22 pmRNSRe-issue of Treasury Shares
19th Dec 20257:00 amRNSBoard Committee Membership Update
19th Dec 20257:00 amRNSBoard Committee Membership Update
16th Dec 202512:12 pmRNSRe-issue of Treasury Shares
15th Dec 20251:20 pmRNSRe-issue of Treasury Shares
5th Dec 20253:49 pmRNSRe-issue of Treasury Shares
1st Dec 202512:55 pmRNSRe-issue of Treasury Shares
26th Nov 202510:57 amRNSHolding(s) in Company
25th Nov 20252:41 pmRNSRe-issue of Treasury Shares
21st Nov 202510:26 amRNSRe-issue of Treasury Shares
20th Nov 20254:22 pmRNSAGM
20th Nov 20257:00 amRNSQ1 Trading Update
14th Nov 20257:00 amRNSHolding(s) in Company
11th Nov 202510:00 amRNSAppointment of Chair Designate
3rd Nov 20257:00 amRNSBlock Listing Six Monthly Return
24th Oct 20253:52 pmRNSPosting of 2025 Annual Report and Notice of AGM
24th Oct 202510:30 amRNS2025 Annual Report and Sustainability Report
21st Oct 202512:39 pmRNSRe-issue of Treasury Shares
20th Oct 20251:08 pmRNSRe-issue of Treasury Shares
20th Oct 202512:44 pmRNSHolding(s) in Company
17th Oct 202512:56 pmRNSRe-issue of Treasury Shares
15th Oct 202512:48 pmRNSRe-issue of Treasury Shares
14th Oct 202511:20 amRNSRe-issue of Treasury Shares
13th Oct 202511:31 amRNSRe-issue of Treasury Shares
10th Oct 20252:32 pmRNSRe-issue of Treasury Shares
9th Oct 202512:02 pmRNSRe-issue of Treasury Shares
8th Oct 20252:30 pmRNSRe-issue of Treasury Shares
6th Oct 202511:54 amRNSRe-issue of Treasury Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.